03 January 2021 : Clinical Research
Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China
Man-Ling Tang1ABCDEF, Yue-Qiu Li2BCDF, Xiang Chen1BCDF, Hui Lin1BCD, Zhong-Chun Jiang2BCD, Dai-Li Gu2BCD, Xun Chen2BCF, Cai-Xi Tang2ACDF, Zhi-Qin Xie2ABCDEFG*DOI: 10.12659/MSM.929783
Med Sci Monit 2021; 27:e929783
Table 3 Risk factors between co-infected and mono-infected COVID-19 patients with multivariate analysis.
P value | OR | 95%CI | |
---|---|---|---|
Sex | 0.512 | 1.711 | (0.344–8.512) |
Age stratification | 0.146 | 0.460 | (0.161–1.312) |
Fatigue | 0.052 | 0.187 | (0.034–1.017) |
Clinical severity classification | 0.849 | 0.842 | (0.144–4.920) |
Onset time(days) | 0.075 | 0.653 | (0.409–1.044) |
PCT >0.1 ng/mL | 0.003 | 0.038 | (0.004–0.341) |
Age stratification includes: ≤20, 21–40, 41–60, >60. PCT – procalcitonin; OR – odds ratio. |